© 2002 Journal of Clinical Pathology
REVIEW
Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency)
1 Department of Immunology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne NE1 4LP, UK
2 Department of Paediatrics, Newcastle upon Tyne Hospitals NHS Trust
Correspondence to:
Correspondence to:
Dr A Fay, Department of Immunology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK;
Fiona.Campbell{at}nuth.northy.nhs.uk
Hereditary angio-oedema is characterised by recurrent swellings in any part of the body and also by recurrent attacks of severe abdominal pain. The disease is inherited in an autosomal dominant manner but up to 25% of cases can occur as a spontaneous mutation. Attacks of swelling can be precipitated by trauma, certain drugs, and emotional stress. Treatment usually involves a combination of prophylaxis, using androgens or antifibrolytic drugs, and replacement with C'1 esterase inhibitor concentrate for acute attacks and before surgery or other traumatic procedures.
Keywords: hereditary angio-oedema; C`1 inhibitor protein; complement activation; treatment
Abbreviations: FFP, fesh frozen plasma; HAE, hereditary angio-oedema; HCV, hepatitis C virus; HGV, hepatitis G virus
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Langran, M, Laird, C
(2004). 8 Management of allergy, rashes, and itching. Emerg. Med. J.
21: 728-741
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
